Tumor-reactive antibodies evolve from non-binding and autoreactive precursors.
Saved in:
| Title: | Tumor-reactive antibodies evolve from non-binding and autoreactive precursors. |
|---|---|
| Authors: | Mazor RD; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel., Nathan N; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel., Gilboa A; Faculty of Engineering, Bar Ilan University, Ramat Gan 52900, Israel., Stoler-Barak L; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel., Moss L; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel., Solomonov I; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel., Hanuna A; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel., Divinsky Y; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel., Shmueli MD; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel., Hezroni H; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel., Zaretsky I; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel; Department of Life Sciences and Core Facilities, Weizmann Institute of Science, Rehovot 7610001, Israel., Mor M; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel., Golani O; Department of Life Sciences and Core Facilities, Weizmann Institute of Science, Rehovot 7610001, Israel., Sabah G; Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel., Jakobson-Setton A; Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel., Yanichkin N; Department of Pathology, Rabin Medical Center, Petah Tikva, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel., Feinmesser M; Department of Pathology, Rabin Medical Center, Petah Tikva, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel., Tsoref D; Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel., Salman L; Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel., Yeoshoua E; Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel., Peretz E; Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel., Erlich I; Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel., Cohen NM; Department of Mathematics and Computer Science, Weizmann Institute of Science, Rehovot 7610001, Israel., Gershoni JM; Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv-Yafo, Israel., Freund N; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel., Merbl Y; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel., Yaari G; Faculty of Engineering, Bar Ilan University, Ramat Gan 52900, Israel., Eitan R; Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel., Sagi I; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel. Electronic address: irit.sagi@weizmann.ac.il., Shulman Z; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel. Electronic address: ziv.shulman@weizmann.ac.il. |
| Source: | Cell [Cell] 2022 Mar 31; Vol. 185 (7), pp. 1208-1222.e21. Date of Electronic Publication: 2022 Mar 18. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35305314 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Tumor-reactive antibodies evolve from non-binding and autoreactive precursors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mazor+RD%22">Mazor RD</searchLink>; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Nathan+N%22">Nathan N</searchLink>; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Gilboa+A%22">Gilboa A</searchLink>; Faculty of Engineering, Bar Ilan University, Ramat Gan 52900, Israel.<br /><searchLink fieldCode="AU" term="%22Stoler-Barak+L%22">Stoler-Barak L</searchLink>; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Moss+L%22">Moss L</searchLink>; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Solomonov+I%22">Solomonov I</searchLink>; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Hanuna+A%22">Hanuna A</searchLink>; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Divinsky+Y%22">Divinsky Y</searchLink>; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Shmueli+MD%22">Shmueli MD</searchLink>; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Hezroni+H%22">Hezroni H</searchLink>; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Zaretsky+I%22">Zaretsky I</searchLink>; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel; Department of Life Sciences and Core Facilities, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Mor+M%22">Mor M</searchLink>; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.<br /><searchLink fieldCode="AU" term="%22Golani+O%22">Golani O</searchLink>; Department of Life Sciences and Core Facilities, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Sabah+G%22">Sabah G</searchLink>; Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.<br /><searchLink fieldCode="AU" term="%22Jakobson-Setton+A%22">Jakobson-Setton A</searchLink>; Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.<br /><searchLink fieldCode="AU" term="%22Yanichkin+N%22">Yanichkin N</searchLink>; Department of Pathology, Rabin Medical Center, Petah Tikva, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.<br /><searchLink fieldCode="AU" term="%22Feinmesser+M%22">Feinmesser M</searchLink>; Department of Pathology, Rabin Medical Center, Petah Tikva, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.<br /><searchLink fieldCode="AU" term="%22Tsoref+D%22">Tsoref D</searchLink>; Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.<br /><searchLink fieldCode="AU" term="%22Salman+L%22">Salman L</searchLink>; Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.<br /><searchLink fieldCode="AU" term="%22Yeoshoua+E%22">Yeoshoua E</searchLink>; Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.<br /><searchLink fieldCode="AU" term="%22Peretz+E%22">Peretz E</searchLink>; Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel.<br /><searchLink fieldCode="AU" term="%22Erlich+I%22">Erlich I</searchLink>; Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel.<br /><searchLink fieldCode="AU" term="%22Cohen+NM%22">Cohen NM</searchLink>; Department of Mathematics and Computer Science, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Gershoni+JM%22">Gershoni JM</searchLink>; Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv-Yafo, Israel.<br /><searchLink fieldCode="AU" term="%22Freund+N%22">Freund N</searchLink>; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.<br /><searchLink fieldCode="AU" term="%22Merbl+Y%22">Merbl Y</searchLink>; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Yaari+G%22">Yaari G</searchLink>; Faculty of Engineering, Bar Ilan University, Ramat Gan 52900, Israel.<br /><searchLink fieldCode="AU" term="%22Eitan+R%22">Eitan R</searchLink>; Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.<br /><searchLink fieldCode="AU" term="%22Sagi+I%22">Sagi I</searchLink>; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel. Electronic address: irit.sagi@weizmann.ac.il.<br /><searchLink fieldCode="AU" term="%22Shulman+Z%22">Shulman Z</searchLink>; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel. Electronic address: ziv.shulman@weizmann.ac.il. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220413066%22">Cell</searchLink> [Cell] 2022 Mar 31; Vol. 185 (7), pp. 1208-1222.e21. <i>Date of Electronic Publication: </i>2022 Mar 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413066 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-4172 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200928674%22">00928674 </searchLink><i>NLM ISO Abbreviation: </i>Cell <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35305314 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.cell.2022.02.012 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1208 Titles: – TitleFull: Tumor-reactive antibodies evolve from non-binding and autoreactive precursors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mazor RD – PersonEntity: Name: NameFull: Nathan N – PersonEntity: Name: NameFull: Gilboa A – PersonEntity: Name: NameFull: Stoler-Barak L – PersonEntity: Name: NameFull: Moss L – PersonEntity: Name: NameFull: Solomonov I – PersonEntity: Name: NameFull: Hanuna A – PersonEntity: Name: NameFull: Divinsky Y – PersonEntity: Name: NameFull: Shmueli MD – PersonEntity: Name: NameFull: Hezroni H – PersonEntity: Name: NameFull: Zaretsky I – PersonEntity: Name: NameFull: Mor M – PersonEntity: Name: NameFull: Golani O – PersonEntity: Name: NameFull: Sabah G – PersonEntity: Name: NameFull: Jakobson-Setton A – PersonEntity: Name: NameFull: Yanichkin N – PersonEntity: Name: NameFull: Feinmesser M – PersonEntity: Name: NameFull: Tsoref D – PersonEntity: Name: NameFull: Salman L – PersonEntity: Name: NameFull: Yeoshoua E – PersonEntity: Name: NameFull: Peretz E – PersonEntity: Name: NameFull: Erlich I – PersonEntity: Name: NameFull: Cohen NM – PersonEntity: Name: NameFull: Gershoni JM – PersonEntity: Name: NameFull: Freund N – PersonEntity: Name: NameFull: Merbl Y – PersonEntity: Name: NameFull: Yaari G – PersonEntity: Name: NameFull: Eitan R – PersonEntity: Name: NameFull: Sagi I – PersonEntity: Name: NameFull: Shulman Z IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 03 Text: 2022 Mar 31 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1097-4172 Numbering: – Type: volume Value: 185 – Type: issue Value: 7 Titles: – TitleFull: Cell Type: main |
| ResultId | 1 |